Oncology

antibodiesDesignImmunotherapeuticsimmunotherapyMedical NewsOncology

Ludwig Lausanne team devises a method to selectively grow tumor-targeting ...

A Ludwig Cancer Research study has devised a highly efficient method to generate large numbers of immune cells specifically engineered ...
Corporate negligenceOncology

J&J Forms Subsidiary to Resolve Talc Claims, It Files for ...

Johnson & Johnson (J&J) announced that LTL Management LLC (LTL), a newly created and separate subsidiary of Johnson & Johnson, ...
ImmunotherapeuticsimmunotherapyOncology

Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C ...

News Release 18-Sep-2021 Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C melanoma ESMO Congress 2021, 16-21 September Reports ...